Novan Welcomes Key Opinion Leaders to New Advisory Council
Dr. Lawrence Eichenfield to Chair Expert Group Focused on Expanding the Breadth of Nitric Oxide Therapies in Dermatology
Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company has formed an Advisory Council comprised of key opinion leaders with broad expertise in dermatology. Novan has recruited these leading physicians based on their reputations as clinical experts to provide medical advice and drug-development insight to the Company’s senior leadership team and board of directors. The Advisory Council will be chaired by Dr. Lawrence Eichenfield, chief of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, vice chair of the Department of Dermatology and professor of dermatology and pediatrics at the University of California, San Diego School of Medicine.